1. Lambl's Excrescences: Association with Cerebrovascular Disease and Pathogenesis
- Author
-
Roldan, Carlos A, Schevchuck, Oleksandr, Tolstrup, Kirsten, Roldan, Paola C, Macias, Leonardo, Qualls, Clifford R, Greene, Ernest R, Hayek, Reyaad, Charlton, Gerald A, and Sibbitt, Wilmer L
- Subjects
Biomedical and Clinical Sciences ,Cardiovascular Medicine and Haematology ,Clinical Sciences ,Atherosclerosis ,Clinical Research ,Brain Disorders ,Heart Disease ,Aging ,Stroke ,Cardiovascular ,Neurosciences ,Lupus ,Adolescent ,Adult ,Cerebrovascular Disorders ,Cross-Sectional Studies ,Echocardiography ,Three-Dimensional ,Echocardiography ,Transesophageal ,Female ,Heart Valve Diseases ,Heart Valves ,Humans ,Incidence ,Longitudinal Studies ,Magnetic Resonance Imaging ,Male ,Middle Aged ,Predictive Value of Tests ,Prevalence ,Prognosis ,Prospective Studies ,Risk Assessment ,Risk Factors ,Time Factors ,Ultrasonography ,Doppler ,Transcranial ,Young Adult ,Lambl's excrescences ,Cerebrovascular disease ,Magnetic resonance imaging ,Transcranial Doppler ,Transesophageal echocardiography ,Neurology & Neurosurgery ,Clinical sciences - Abstract
BackgroundLambl's excrescences (LEx) are detected by transesophageal echocardiography (TEE) and are characterized as thin, elongated, and hypermobile structures located at the leaflets' coaptation point of the heart valves. The association of LEx with cerebrovascular disease (CVD) is still undefined and yet patients with LEx and suspected CVD receive unproven effective antiplatelet or anticoagulant therapy or even undergo valve surgery. Also, the association of LEx with aging and atherogenic, inflammatory, or thrombogenic parameters has not been reported.MethodsSeventy-seven patients with systemic lupus erythematosus (SLE) (71 women, age 37 ± 12 years) and 26 age- and sex-matched healthy controls (22 women, age 34 ± 11 years) prospectively underwent routine history and physical exam, transcranial Doppler, brain MRI, TEE, carotid duplex, and clinical and laboratory evaluations of atherogenesis, inflammation, platelet activity, coagulation, and fibrinolysis. Subjects without stroke/TIA on enrollment (with and without LEx) had a median follow-up of 57 months.ResultsOn enrollment, 33 (43%) of 77 patients had CVD manifested as acute stroke/TIA (23 patients), cerebromicroembolism by transcranial Doppler (17 patients), or cerebral infarcts by MRI (14 patients). Mitral or aortic valve LEx were equally frequent in healthy controls (46%) as in patients with and without any CVD (39 and 43%), stroke/TIA (35 and 43%), cerebromicroembolism (41 and 42%), or cerebral infarcts (36 and 43%) (all p ≥ 0.72). Also, other mechanisms for CVD other than LEx such as Libman-Sacks vegetations, patent foramen ovale or interatrial septal aneurysm, aortic or carotid atherosclerosis, or thrombogenesis were found in ≥94% of patients with CVD. In addition, 36 subjects with and 44 without LEx had similar low incidence of stroke/TIA (1 (1.3%) and 2 (2.5%), respectively, p = 1.0) during follow-up. Finally, LEx were not associated with aging, atherogenic risk factors, atherosclerosis, inflammation, or thrombogenesis.ConclusionsIn this study, LEx are similarly prevalent in healthy controls and SLE patients, are not associated with CVD, and are not associated with pathogenic risk factors. Therefore, the study findings suggest that LEx may not be cardioembolic substrates, may not represent pathologic valve structures, and may not require therapy.
- Published
- 2015